EUVIMEDEUVIMED entdecken
Crossref

Regulation of Botulinum neurotoxin half‑life through the ubiquitin‑proteasome system

Hae-Seul Choi, Hye-Rim Seo, Miso Choi, Hwa-Yeong Kim, Sun-Kyu Jin, Myunghoon Lee, Kwang-Hyun Baek

Molecular Medicine Reports · 2025

DOI: 10.3892/mmr.2025.13633 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Medicine Reports, 2025. Verfasst von Hae-Seul Choi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioconvergence, CHA University, Seongnam, Gyeonggi 13488, Republic of Korea. Hauptthemen laut MEDLINE: Proteasome Endopeptidase Complex, Ubiquitin, Botulinum Toxins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Botulinum neurotoxin (BoNT), renowned for its potency, is used in both therapeutic and cosmetic applications; however, it is constrained by a relatively short half‑life and limited duration of efficacy. The present study investigated the role of the ubiquitin‑proteasome system in BoNT degradation and evaluated strategies to extend its half‑life by targeting specific lysine residues. Ubiquitination was observed in the light chains of BoNT/A1 (K335 and K417), BoNT/A2 (K335) and BoNT/E (K62 and K288), which were identified as key ubiquitination sites. The substitution of these lysine residues to arginine inhibited ubiquitination, improving protein stability and extending the half‑life of BoNT. These findings offer a potential strategy to enhance the therapeutic efficacy of BoNT by prolonging its stability, paving the way for future advancements in BoNT‑based treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proteasome Endopeptidase ComplexUbiquitinBotulinum ToxinsUbiquitinationHalf-LifeHumansProteolysisLysineProtein StabilityAnimals

Stichwörter der Autor:innen

Botulinum neurotoxinSNAP‑25bioinformaticsprotein half‑lifeubiquitination

Substanzen

Proteasome Endopeptidase ComplexUbiquitinBotulinum ToxinsLysine

Autor:innen und Institutionen

  • Department of Bioconvergence, CHA University, Seongnam, Gyeonggi 13488, Republic of Korea.
  • Alkemier Inc., Seoul 05855, Republic of Korea.
  • Department of Biomedical Science, CHA University, Seongnam, Gyeonggi 13488, Republic of Korea.

Zitieren

APA

Choi, H. S., Seo, H. R., Choi, M., Kim, H. Y., Jin, S. K., Lee, M., & Baek, K. H. (2025). Regulation of Botulinum neurotoxin half‑life through the ubiquitin‑proteasome system. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2025.13633

Vancouver

Choi HS, Seo HR, Choi M, Kim HY, Jin SK, Lee M, et al. Regulation of Botulinum neurotoxin half‑life through the ubiquitin‑proteasome system. Molecular Medicine Reports. 2025. doi:10.3892/mmr.2025.13633

BibTeX
@article{Choi2025,
  author = {Choi, Hae-Seul and Seo, Hye-Rim and Choi, Miso and Kim, Hwa-Yeong and Jin, Sun-Kyu and Lee, Myunghoon and Baek, Kwang-Hyun},
  title = {Regulation of Botulinum neurotoxin half‑life through the ubiquitin‑proteasome system},
  journal = {Molecular Medicine Reports},
  year = {2025},
  doi = {10.3892/mmr.2025.13633}
}
Kostenlos starten →